Shaanxi Xinghua ChemistryLtd Past Earnings Performance
Past criteria checks 0/6
Shaanxi Xinghua ChemistryLtd's earnings have been declining at an average annual rate of -21.6%, while the Chemicals industry saw earnings growing at 8.5% annually. Revenues have been growing at an average rate of 15.1% per year.
Key information
-21.6%
Earnings growth rate
-21.3%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 15.1% |
| Return on equity | -8.6% |
| Net Margin | -11.8% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Shaanxi Xinghua ChemistryLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 3,808 | -449 | 168 | 0 |
| 31 Dec 23 | 3,572 | -411 | 162 | 0 |
| 30 Sep 23 | 3,513 | -291 | 121 | 0 |
| 30 Jun 23 | 3,003 | -211 | 113 | 0 |
| 31 Mar 23 | 2,949 | 48 | 105 | 0 |
| 31 Dec 22 | 3,258 | 394 | 105 | 0 |
| 30 Sep 22 | 3,176 | 524 | 120 | -3 |
| 30 Jun 22 | 3,333 | 676 | 107 | 0 |
| 31 Mar 22 | 3,118 | 653 | 105 | 0 |
| 01 Jan 22 | 2,837 | 539 | 99 | 0 |
| 30 Sep 21 | 2,840 | 611 | 125 | -8 |
| 30 Jun 21 | 2,455 | 448 | 112 | 0 |
| 31 Mar 21 | 2,226 | 325 | 100 | 0 |
| 31 Dec 20 | 1,940 | 214 | 92 | 0 |
| 30 Sep 20 | 1,794 | 125 | 63 | 11 |
| 30 Jun 20 | 1,825 | 102 | 79 | 0 |
| 31 Mar 20 | 1,816 | 98 | 72 | 0 |
| 31 Dec 19 | 1,974 | 146 | 71 | 0 |
| 30 Sep 19 | 1,988 | 158 | 104 | 0 |
| 30 Jun 19 | 2,023 | 213 | 90 | 0 |
| 31 Mar 19 | 2,027 | 227 | 97 | 0 |
| 31 Dec 18 | 2,053 | 238 | 102 | 0 |
| 30 Sep 18 | 2,074 | 266 | 67 | 0 |
| 30 Jun 18 | 2,011 | 232 | 62 | 0 |
| 31 Mar 18 | 1,937 | 214 | 50 | 0 |
| 31 Dec 17 | 1,894 | 206 | 55 | 0 |
| 30 Sep 17 | 1,908 | 185 | 64 | 0 |
| 30 Jun 17 | 1,988 | 166 | 107 | 0 |
| 31 Mar 17 | 2,198 | 151 | 143 | 0 |
| 31 Dec 16 | 2,038 | 28 | 159 | 0 |
| 30 Sep 16 | 3,159 | -79 | 245 | 0 |
| 30 Jun 16 | 2,858 | -125 | 228 | 0 |
| 31 Mar 16 | 2,476 | -183 | 219 | 0 |
| 31 Dec 15 | 2,290 | -144 | 214 | 0 |
| 30 Sep 15 | 878 | -164 | 151 | 0 |
| 30 Jun 15 | 918 | -168 | 158 | 0 |
| 31 Mar 15 | 891 | -165 | 167 | 0 |
| 31 Dec 14 | 948 | -151 | 169 | 0 |
| 30 Sep 14 | 1,019 | -60 | 170 | 0 |
| 30 Jun 14 | 1,019 | -19 | 171 | 0 |
| 31 Mar 14 | 1,078 | 36 | 169 | 0 |
| 31 Dec 13 | 1,119 | 61 | 171 | 0 |
| 30 Sep 13 | 1,139 | 43 | 177 | 0 |
| 30 Jun 13 | 1,233 | 71 | 193 | 0 |
Quality Earnings: 002109 is currently unprofitable.
Growing Profit Margin: 002109 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002109 is unprofitable, and losses have increased over the past 5 years at a rate of 21.6% per year.
Accelerating Growth: Unable to compare 002109's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 002109 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-19.8%).
Return on Equity
High ROE: 002109 has a negative Return on Equity (-8.61%), as it is currently unprofitable.